



A Simple Method to Model a Continuous Glucose Monitoring Signal 
 
Felicity Thomas, * Christopher Pretty, * Jennifer Dickson, * Matthew Signal,* Geoffrey Shaw, ** J. Geoffrey Chase* 

* Department of Mechanical Engineering, University of Canterbury, 
Christchurch, New Zealand (e-mail: chris.pretty@canterbury.ac.nz). 
** Department of Intensive Care, Christchurch Hospital, 
Christchurch, New Zealand 
Abstract: Before continuous glucose monitoring (CGM) can be safely used to guide glycaemic control 
(GC) protocols the impact of suboptimal accuracy resulting from error or delay in calibration measurement, 
sensor drift, and delayed glucose diffusion must first be characterised. Characterising this error allows 
models to be formed so in-silico simulations can test the performance and safety of CGM driven glycaemic 
control protocols and examine best and worst scenarios. Existing models of CGM dynamics are now 10 
years old and significant advances in sensor technology mean the level of error produced by these models 
no longer characterises the dynamics of more recent CGM devices. Therefore, this paper presents and 
validates a simple CGM error model based on the latest available CGM devices, as well as a generalisable 
sensor modeling approach. 
The model was created using 28 data sets from an observational pilot study of CGM in patients admitted 
to the Christchurch Hospital ICU during 2014-15. The model was characterised by empirical models of 
drift and noise. Autocorrelation was then used to validate the modelled data with the measured data. The 
median absolute difference between modelled and measured SG autocorrelation values was 0.007 with a 
range of 0 – 0.13. Hence, the model is judged to be suitable for use in simulation to provide better insight 
into using CGM to guide GC will effect control and its safety and performance. The overall modelling 
process is data driven and readily generalised to any other device.  
Keywords: Developments in measurement, signal processing, Identification and validation, Error 
quantification, Time series modelling, Healthcare management, disease control, critical care   
1. INTRODUCTION 
Two in-silico studies (Signal et al., 2010, Mombaerts et al., 
2015) and a recent pilot observational trial (Signal et al., 2013) 
have shown that continuous glucose monitoring (CGM) 
devices, when coupled with a well-designed glycaemic control 
(GC) protocol, offer several potential benefits over the 
standard practice of intermittent blood glucose (BG) 
monitoring. These studies have shown CGM devices have the 
ability to reduce hypoglycaemia, maintain BG control, and 
reduce nurse workload.  
 
Typical glycaemic control protocols require BG measurements 
every 1-4 hours (Evans et al., 2012, Lonergan et al., 2006, 
Plank et al., 2006, Blaha et al., 2009), typically resulting in ~6 
- 14 blood draws a day per patient. This frequency can 
represent a measurable part of total nurse workload (Carayon 
et al., 2005, Holzinger et al., 2005). CGM devices have the 
potential to drastically reduce the number of BG 
measurements per day, positively impacting workload, while 
also improving patient safety and increasing time in the desired 
BG target band.  
 
However, CGM devices tend to have suboptimal accuracy 
resulting from error or delay in calibration measurement, 
sensor drift, and delayed glucose diffusion (O’Sullivan et al., 
2007, Heath et al., 1983). Thus, before CGM can become 
ubiquitous in the care of critically ill patients these errors on 
BG control must first be quantified and understood. 
Subsequently, their interaction with GC protocols and 
resulting impact on performance and safety can be assessed.     
 
Despite significant outpatient use and promise for CGM 
(Breton et al., 2008, Klonoff, 2005a, Klonoff, 2005b) the 
literature contains very few reports of error models derived 
from clinical sensor glucose (SG) data. Without a good model 
of CGM dynamics the feasibility of CGM combined with GC 
cannot be assessed in-silico.  Two studies have provided 
sufficient details of CGM device error characteristics to allow 
models to be created or reproduced for use in-silico (Breton et 
al., 2008, Goldberg et al., 2004). However, these models are 
now 10 years old and significant advances in sensor 
technology mean the level of error produced by these models 
no longer characterises the dynamics of more recent CGM 
devices. Therefore, this paper presents and validates a simple 
CGM error model based on the latest available CGM devices. 
 
2. PATIENTS & METHODS 
2.1 Patients 
This study uses data from an observational pilot study of CGM 
in patients admitted to the Christchurch Hospital ICU during 
2014-15. All patients were recruited by a physician in the ICU 
and informed written consent obtained. If the patient was 
unable to consent next of kin were approached for consent and 
follow up consent was obtained from the patient at a later date 
if applicable.  Inclusion criteria were: 




8 mmol/L,  indicating  the  need  for insulin  therapy  
using  the  STAR  protocol (Evans et al., 2012) 
 Expected admission of at least 3 days  
 Over 18 years of age 
 A platelet count > 30,000/mL.   
Patients were excluded if they were not expected to survive, 
receiving hydroxyurea, pregnant, and/or lacked clinical 
equipoise. This study and use of  data  was  approved  by  the  
Upper  South  A  Regional  Ethics  Committee, New Zealand 
(URA/12/02/004). Table 1 shows the patient demographics. 
 
Table 1. Patient demographics displayed as median [IQR] 
where appropriate. APACHE II = Acute Physiology and 
Chronic Health Evaluation II. 
Patients 21 
Ages (years) 60 [55 – 68] 
Sex (M/F) 11/9 
APACHE II score 20 [16 – 25] 
Outcome (L/D) 14/7 
 
All patients were monitored for a period of up to 3 days using 
the Sentrino monitoring system (Medtronic, MiniMed, 
Northridge, California). Patients had either one abdomen and 
one thigh sensor, two abdomen sensors, or one thigh sensor 
inserted by a trained clinician, depending on which trial phase 
they were enrolled in.  Calibration BG measurements were 
obtained by specifically trained ICU nurses at least  3  times  
per  day  as  recommended  by  the  device  manufacturer  
(MiniMed, 2014). BG measures were obtained using the 
Roche Accu-chek Inform II (F. Hoffmann-La Roche Ltd, 
Basle, Switzerland) hospital grade glucose meters as is 
standard practice in the Christchurch ICU, with blood typically 
obtained from an arterial line. CGM devices were strictly not 
used for determining treatment for GC during this study. 
 
In addition to BG measurements used for calibration of SG 
data, each patient had intermittent BG monitoring every few 
hours.  The  STAR  protocol  requires,  on average,  12-14  BG  
measurements  per  day  to  guide  insulin/nutrition  therapy 
(Fisk et al., 2012). These additional reference measurements 
can be used to assess CGM accuracy.  
 
Each SG signal was treated separately for modelling purposes. 
Three patients were excluded from the analysis, Patients 17, 
21 and 24. These patients had early sensor failure and were 
deemed clinically unsuitable for replacement sensors. In each 
case, not enough data was collected from these patients to be 
relevant to the model. Additionally, any data characteristic of 
a failed sensor or uncharacteristic of a sensor signal was 
removed, shown in Appendix A. This removal resulted in 28 
separate SG signals for analysis. Table 2 summarises the data 
used for modelling and validation.   
 
Table 2: Data used for modelling and validation 
No. SG signals 28 
No. SG hours 1689 
No. Calibration measurements 380 
No. Reference measurements 669 
2.3 Model development 
The error in a CGM signal can be broken down into separate 
parts specifically, the true BG signal noise and drift:  
    𝐶𝐺𝑀 = 𝐵𝐺𝑟𝑒𝑎𝑙 + 𝑛𝑜𝑖𝑠𝑒 + 𝑑𝑟𝑖𝑓𝑡               (1) 
 
Where noise is the random error centred about 0 and drift is a 
linear bias between calibration measurements. Noise and drift 
were modelled based on clinical Sentrino data to create a CGM 
model with outputs added to reference blood glucose values to 
simulate the impact of CGM error on GC results.  
 
A constant drift rate with a linear bias, was assumed for the 
drift model, based on clinical observation and prior data. Drift 
was defined as the rate of increase in discrepancy between 
CGM signal and calibration BG measurements. The drift 
profile between any two calibration BG measurements was 
then defined by delta, the accumulated drift magnitude. The 
magnitude of accumulated drift between any two calibration 
BGs was found by measuring the size of the bias (CGM value 
– Calibration BG) at the second calibration BG as shown in 
Figure 1.  Once delta is identified for each calibration 
measurement it can be removed from the SG for further 
analysis. This calculation resulted in a new drift-corrected 
CGM profile as shown in Figure 1.   
 
Fig 1. Example of accumulated drift in a SG signal and a 
SG signal once drift is removed 
 
The sections between each calibration measurement were 
considered independently because calibration should correct 
for any drift. Autocorrelation of the delta data shows no 
tendency for a sensor to repeatedly drift in the same direction, 
as shown in Figure 2.  Autocorrelation is the dot product of the 
signal after it has been shifted in time by some amount. The 
resultant angle, θ, shows the trend similarity between two 
vectors and its cosine has values from -1 and +1 demonstrating 
opposing to complete agreement. A lag window of up to 10 
minutes was considered. Therefore, the similarity of the signal 
to itself was compared every minute from 10 minutes before 








mean shifted before autocorrelation was applied to remove 
bias. 
 
Fig 2. The autocorrelation of the delta drift data over a lag 
window of +10 and -10 minutes, for all data points. There 
is no correlation evident within this window.  
 
An empirical model of drift was implemented from the 
cumulative distribution function (CDF) of the delta data across 
the entire cohort using inverse transform sampling. This 
method is implemented by interpolating the CDF to 100,000 
points to ensure a smooth curve. A uniform random number 
generator then selects a value in the range 0 – 1 which was then 
used to obtain the corresponding interpolated CDF delta value. 
The process can be repeated resulting in a dataset that has the 
same distribution as per the empirical data.  
 
Sensor noise contributes the remaining zero mean, random 
error to the modelled CGM signal of Equation 1. Noise was 
split into two components, low and high frequency noise.  Low 
frequency noise is considered “the long duration” sensor noise, 
or, in this case, the difference between reference BG and the 
SG once drift is removed. High frequency noise is the “minute 
to minute” noise that gives the SG signal a jagged appearance.   
 
The low frequency noise was considered to be the difference 
between each independent reference BG and the drift-
corrected SG signal. Low frequency noise accounts for the 
error that occurs intermittently over longer time periods, which 
could be induced by events such as turning or other accidental 
pressure applications on the sensor site (Helton et al., 2011a, 
Helton et al., 2011b). As was done for the drift data, an 
empirical model was generated from a CDF of low frequency 
noise by inverse sampling.  
 
Unlike low frequency sensor noise, high frequency sensor 
noise occurs minute-to-minute and results in the 'jagged' 
appearance of the CGM signal. High frequency noise 
represents electrical noise, random variation induced by the 
imperfect reading and transmission of the sensor signal.  High 
frequency noise is very small in magnitude thus does not affect 
the identification of low frequency noise. A simple model was 
created using the CGM data by calculating the size of the 
changes in glucose from sample to sample (every minute).  The 
sample-to-sample change was then halved to obtain an 
amplitude because noise is assumed to be zero mean so 
sample-to-sample changes would double the amplitude found 
over many measurements. Thus, it yields an independent, 
random added noise with sample-to-sample changes similar to 
those observed in the empirical data. 
 
2.4  Model development 
To ensure the CGM model produced similar dynamics to the 
CGM sensors, the 28 data sets containing true reference and 
calibration BGs provided the framework to generate modelled 
SG signals. The reference and calibration BGs were linearly 
interpolated to give a 'true BG signal'. CGM drift, and noise 
are added to this ‘true BG signal’, as shown in subplot A of 
Figure 3.   
 
Fig 3. Example of the process undertaken to model a SG 
signal. First the BG measurements are interpolated, A. 
Then drift, low frequenacy and high frenquency error are 
found by sampling from their emperical distributions, B, 
D and C respectively. Finally, the error is added to the 
interpolated BG to prove the simulated signal, E.   
 
A drift profile was then created using the empirical drift model 
to randomly generate a drift delta value for each 8 hour 
calibration interval, as shown in subplot B of Figure 3.  A low 
frequency noise profile created by sampling every 160 minutes 
from the low frequency error model. Samples were taken at 
160 min intervals as opposed to at the time of reference BG 
measurements because some data sets contained infrequent 
reference BG measurements and the mean reference 
measurement interval across the available dataset was 160 
minutes. Consecutive samples were linearly interpolated and a 
median filter was used to smooth the error signal, as shown in 









uncharacteristic sharp edges introduced by the linear 
interpolation between the error points.   Finally, a high 
frequency noise profile was generated every minute by 
randomly sampling from the empirical high frequency model, 
as shown in subplot D of Figure 3. The summed result of each 
component yields a simulated true BG with CGM error, as 
shown in Figure 3 subplot E.  
 
The overall model development method is general and data 
driven. The use of drift and random errors is general, as these 
can occur in any such device, and if they don’t, they are 
essentially set to zero by their absence. Thus, given data from 
another sensor, a similar model could be generated and 
similarly tested and validated. 
 
2.5 Model Validation 
The CGM model is a created using random process. Therefore, 
it cannot be deterministically compared to actual measured 
CGM data and, importantly, no two uses of the model for the 
same true BG data yield the same result. Thus, to validate the 
modelled signals, autocorrelation was used to assess the 
similarity of the simulated CGM signals to the original CGM 
data.  
 
All signals were first mean shifted to remove bias before 
autocorrelation was applied. If the resulting autocorrelation 
coefficients of the simulated SG and real SG are similar then 
the model can be considered to provide a realistic 
approximation of the sensor dynamics. The auto-correlation 
coefficients can be statistically assessed over several runs of 
the model for any given real SG trace. 
 
A total of 50 model-derived SG signals were simulated for 
each patient and the autocorrelation coefficient was calculated 
between the real SG and each simulated SG signal over a +10 
mins to -10 mins window. The median and range of correlation 
coefficients of the modelled SG was then compared to the 
correlation coefficient of the measured SG. The closer the 
agreement between the correlation coefficients of the 
simulated signals, and the correlation coefficient of the real 
CGM signal the better the model.  
 
3. RESULTS & DISCUSSION 
Visually and qualitatively, the CGM model generates similar 
signals to the empirical data. An example signal is shown in 
Figure 4 with real SG and 3 simulated signals. In particular, it 
is difficult to distinguish the real CGM signal from the 
modelled signals. 
 
Figure 5 displays the median and range of autocorrelation 
values for each time lag for each patient’s modelled SG 
signals. The modelled SG show very similar autocorrelation 
trends to those displayed by the measured data. Measured SG 
is less tightly correlated than the median modelled SG in the 
majority of cases. However, only 3/28 measured SG values (A, 
B and C in Figure 5) do not sit within the range of modelled 
SG across all of the 20 minute (+/- 10 minute) windows and 
the median difference between the modelled and measured SG 
correlation values was 0.007 with a range of 0 – 0.13, the 
biggest differences occurring at the +10 or -10 minute time 
shift, where correlation might generally be expected to be 
weaker given the time difference from the original model.   
Fig. 4. Comparing the original SG signal to that of three 
different modelled signals using the CGM modelled 
generated from empirical data 
 
 
The SG of the three instances (A, B and C in Figure 5) where 
the measured SG autocorrelation does not fall within the range 
of modelled SG autocorrelation for all time lags are shown in 
Figure 6. It is evident the lack of agreement is most likely due 
to individual cases where the sensor did not behave as 
expected. Thus, in these limited cases, the behaviour of the 
sensor as seen in the data cannot be easily explained by the 
noise and error types defined.  
 
In this figure, subplot A corresponds to the A in Figure 5 and 
the high frequency noise has increased noticeably about 
halfway through the signal which is not seen in any of the other 
28 SG signals. Subplot B corresponds to the SG of Figure 6B. 
The sensor glucose has many small unusual spikes 
uncharacteristic of the other sensors. Subplot C corresponds to 
Figure 6C where there is a large drop out at 300 minutes in SG 
compared to an otherwise stable signal with some strange 
spikes.   
 
Additionally, over all patients sensor glucose is very tightly 
correlated in both measured and modelled SG. This result is 
logical as the rate of which blood glucose can change is 
physiologically limited and under normal conditions blood 
glucose will be related over a short time period, such as 10 
minutes.  However, if the time lag is extended to ±20 or ±30 
minutes the correlation coefficients of both the modelled SG 





Fig 5. Comparing the autocorrelation coefficients for the 
real SG to the median and range correlation coefficients of 
the modelled SG. A, B, and C are where the measured SG 
autocorrelation does not fall within the range of modelled 
SG autocorrelation.   
 
 
Fig 6. The sensor glucose for the three instances where the 
autocorrelation range of the modelled SG does not include 
the autocorrelation of the measured SG for all time lags. A, 
B and C correspond to the A, B and C of Figure 5. 
 
3.1 Limitations  
This analysis is limited by only have 28 data sets to generate 
the model from. A larger cohort would provide more data to 
generate the empirical models from. However, the consistency 
of the autocorrelation coefficients of the simulated signals to 
the real SG value indicates there is enough data to provide an 
acceptable model. Equally, as more data is aggregated from 
any given sensor type in use, the modeling methodology is 
more than general enough to be updated as required,  
 
Notably, the same updating approach would also apply as 
sensors improve over different design changes and sensor 
generations. An equally applicable aspect of the model and its 
ability to update would include the ability to see, by tracking 
sensor data in use, if sensor performance changed, for better or 
worse. Such changes can occur, for one example, due to 
changes in design or manufacturing that impact sensor 
performance directly or in clinical use. 
 
A further limitation is the limited choice of noise/error types. 
However, the 3 choices cover most variations observed 
clinically without adding extra complexity and unnecessary 
dynamics. Finally, this model is limited by the fact it is data 
driven, not a dynamic, deterministic model.  The benefits of 
this method are that it simplifies the process of calculating 
exact dynamic and electronic, physiological and other noise 
causes/sources.   
 
3. CONCLUSIONS 
The CGM error model generated using the Sentrino data 
provides a realistic SG signal. Only 3 of 28 measured SG 
values do not sit with in the range of modelled SG across the 
entire 20 minute window considered. The median absolute 
difference between modelled and measured SG 
autocorrelation values was 0.007 with a range of 0 – 0.13. 
Hence, the model is judged to be suitable for use in simulation 
to provide better insight into using CGM to guide GC will 
effect control and its safety and performance. The overall 
modelling process is data drive and readily generalised to any 
other CGM.  
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Appendix A. FIRST APPENDIX 
 
Fig A1. The sensor glucose that was removed from 6 
patients data due to being uncharacteristic of the sensor, 
most commonly as the result of sensor failure.  
 
